SRTA (Strata Critical Medical) Shares Outstanding (EOP): 86.5 Mil (As of Mar. 2026)


SRTA Strata Critical Medical Inc SRTA
70 GF Score
Price $5.21
GF Value $4.47
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Strata Critical Medical Shares Outstanding (EOP)?

Strata Critical Medical SRTA +0.48% 70 Shares Outstanding (EOP) is 86.5 Mil as of Mar. 2026. GuruFocus rates SRTA with a GF Score™ of 70/100 and a GF Value™ of $4.47 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Strata Critical Medical's shares outstanding for the quarter that ended in Mar. 2026 was 86.5 Mil.

Strata Critical Medical's quarterly shares outstanding declined from Dec. 2025 (86.7 Mil) to Mar. 2026 (86.5 Mil). It means Strata Critical Medical bought back shares from Dec. 2025 to Mar. 2026 .

Strata Critical Medical's annual shares outstanding increased from Dec. 2024 (79.4 Mil) to Dec. 2025 (86.7 Mil). It means Strata Critical Medical issued new shares from Dec. 2024 to Dec. 2025 .


Strata Critical Medical  (NAS:SRTA) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Strata Critical Medical Shares Outstanding (EOP) Related Terms


Strata Critical Medical Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Strata Critical Medical's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Strata Critical Medical Shares Outstanding (EOP) Chart

Strata Critical Medical Annual Data
Trend Sep19 Sep20 Sep21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial 70.10 71.66 75.13 79.42 86.70

Strata Critical Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.97 81.70 86.05 86.70 86.52

SRTA vs CYH, CCRN, AUNA: Shares Outstanding (EOP) Comparison

For the Medical Care Facilities subindustry, Strata Critical Medical's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Strata Critical Medical Shares Outstanding (EOP) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Strata Critical Medical's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Strata Critical Medical's Shares Outstanding (EOP) falls into.


SRTA
70GF Score
Strata Critical Medical Inc SRTA
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Strata Critical Medical Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 86.5 Mil mean?
Strata Critical Medical (SRTA) has a Shares Outstanding (EOP) of 86.5 Mil as of Mar. 2026. The total shares a company has outstanding, at period-end. View historical data on Strata Critical Medical and its competitors.
Is Strata Critical Medical's Shares Outstanding (EOP) too high?
Strata Critical Medical's current Shares Outstanding (EOP) is 86.5 Mil. Overall, Strata Critical Medical has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Strata Critical Medical's Shares Outstanding (EOP) compare to CYH and CCRN?
Strata Critical Medical's Shares Outstanding (EOP) of 86.5 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Healthcare Providers & Services company?
A good Shares Outstanding (EOP) depends on the Healthcare Providers & Services industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Strata Critical Medical and its competitors. Strata Critical Medical's current Shares Outstanding (EOP) is 86.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Strata Critical Medical stock overvalued right now?
Based on GuruFocus' analysis, Strata Critical Medical (SRTA) is currently considered Modestly Overvalued. The stock's GF Value™ is $4.47, compared to a current price of $5.21 — trading 16.4% above its estimated fair value. The current Shares Outstanding (EOP) is 86.5 Mil. Strata Critical Medical's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Strata Critical Medical (SRTA), the current Shares Outstanding (EOP) is 86.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Strata Critical Medical (SRTA) Overvalued in 2026?

Based on GuruFocus' analysis, Strata Critical Medical stock appears to be overvalued. The current stock price of $5.21 is trading 16.4% above its estimated GF Value™ of $4.47. GuruFocus considers Strata Critical Medical to be Modestly Overvalued.

Key valuation signals for SRTA:

  • Shares Outstanding (EOP): 86.5 Mil
  • GF Value™: $4.47 vs. price of $5.21 (16.4% above fair value)
  • GF Score™: 70/100 with 4 warning signs

No single metric tells the full story. See the SRTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Strata Critical Medical Business Description

Address 31 Hudson Yards, 14th Floor, New York, NY, USA, 10001
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.
70GF Score

Get the complete analysis for SRTA

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.21
Price
$4.47
GF Value